← Back to feed

Tristel

TSTL · AIM · Health Care · mcap £199m today

All announcements

All RNS · 37 Key events · 26

11 Aug 26

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9716336 ↗
31 Jul 26

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9698329 ↗
27 Jul 26

3T Pro commercial launch

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces the commercial launch of 3T Pro, a premium tier within its 3T digital compliance platform.
RNS 9687777 ↗
22 Jul 26

Positive Trading Update

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces a trading update for the year ended 30 June 2026 ("FY 2026").
RNS 9680616 ↗
07 Jul 26

APIC26 Annual Conference attendance

Strong clinical engagement and growing U.S. presence at largest annual infection prevention conference
RNS 9654923 ↗
17 Jun 26

Appointment of CEO New CEO

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces the appointment of Christopher ("Chris") Lee as Chief Executive Officer ("CEO"), with effect from 1 August 2026.
RNS 9621835 ↗
10 Jun 26

Exercise of Share Options & Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9610045 ↗
13 May 26

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9566393 ↗
05 May 26

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9550694 ↗
23 Mar 26

Director/PDMR Shareholding Director buys

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it was notified on 20 March 2026 that Caroline Stephens, Non-Executive Director of the Company, purchased 2,597 ordinary shares of 1 penny each in the Company...
RNS 9485810 ↗
18 Mar 26

Conference attendance at ShareSoc Leeds

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Tristel will be presenting at the ShareSoc Growth Company investor event on 14 April 2026, which will be held at Clayton Hotel, City Walk, Sweet Street, Leeds, LS11 9AT.
RNS 9479290 ↗
03 Mar 26

PCA Dealing Director buys

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it was notified on 3 March 2026 that Glenn Stephens, a PCA of Caroline Stephens, Non-Executive Director of the Company, purchased 2,310 ordinary shares of 1 penny...
RNS 9456638 ↗
02 Mar 26

Half-year Results

Unaudited Interim Results for the six months ended 31 December 2025
RNS 9452092 ↗
12 Feb 26

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9426803 ↗
06 Feb 26

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9415277 ↗
22 Jan 26

Positive H1 Trading Update & Directorate Change New CEOHolder at 25–30 %

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces a positive trading update for the six months ended 31 December 2025.
RNS 9374570 ↗
08 Jan 26

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9342233 ↗
12 Dec 25

Director/PDMR Shareholding Director buys

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that, on 11 December 2025, Tom Jenkins, Non Executive Director of the Company, purchased 5,400 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a...
RNS 9293319 ↗
12 Dec 25

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9293102 ↗
11 Dec 25

AGM Statement

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, will hold its Annual General Meeting at 11am today at the offices Company's headquarters, Unit 1b Lynx Business Park, Fordham Road Snailwell, Newmarket, Cambridgeshire, CB8 7NY.
RNS 9289115 ↗
24 Nov 25

Director Option Grant

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that on 24 November 2025 it granted a total of 181,972 new share options (the "Options") over ordinary shares of 1 pence each ("Ordinary Shares") under the Long Term...
RNS 9253500 ↗
24 Nov 25

Updated US guidelines for high level disinfection

American Institute of Ultrasound in Medicine expands U.S.
RNS 9251891 ↗
16 Oct 25

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9176125 ↗
13 Oct 25

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9167551 ↗
13 Oct 25

Final Results

Another year of double-digit revenue growth, 23% growth in adj. pre-tax profits and strong cash generation
RNS 9165875 ↗
09 Oct 25

Exercise of Share Options and Total Voting Rights

Exercise of Share Options and Total Voting Rights
RNS 9160796 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.